Vetter Opens Technologically Advanced Service Facility in the U.S., Strengthening Commitment to North American Market
Working hand-in-hand with customers from clinical development through to market launch has allowed Vetter to develop an ideal mode of delivery for highly sensitive, active ingredients. With its new location in the heart of the United States, Vetter can now process and test small quantities of materials by bringing the development process closer to many key customers, enabling greater cooperation at the earliest stages of development and minimizing the need to transport products.
For Vetter’s many North American customers, a shorter time to market will soon be facilitated, by its Chicago location according to Peter Soelkner, Managing Director at Vetter. “The opening of this new cutting-edge VDS facility shows Vetter’s firm, strategic commitment to the North American market by bringing the state of the art technology to the heart of the U.S.,” said Peter Soelkner. “The support VDS delivers throughout the entire product development cycle can now start earlier, and the proximity to our customers will contribute to streamlining the process and delivering the final product faster.”
Located in Chicago, the new approx 25.000 square feet VDS facility will open end of 2009.
Other news from the department manufacturing
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.